These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 7760095)
1. A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: a comparison to 9L gliosarcoma. Kruse CA; Molleston MC; Parks EP; Schiltz PM; Kleinschmidt-DeMasters BK; Hickey WF J Neurooncol; 1994; 22(3):191-200. PubMed ID: 7760095 [TBL] [Abstract][Full Text] [Related]
2. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. Barth RF J Neurooncol; 1998 Jan; 36(1):91-102. PubMed ID: 9525831 [TBL] [Abstract][Full Text] [Related]
3. Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma. Saito R; Bringas J; Mirek H; Berger MS; Bankiewicz KS J Neurosurg; 2004 Nov; 101(5):826-31. PubMed ID: 15540922 [TBL] [Abstract][Full Text] [Related]
4. Leptomeningeal tissue: a barrier against brain tumor cell invasion. Pedersen PH; Rucklidge GJ; Mørk SJ; Terzis AJ; Engebraaten O; Lund-Johansen M; Backlund EO; Laerum OD; Bjerkvig R J Natl Cancer Inst; 1994 Nov; 86(21):1593-9. PubMed ID: 7932823 [TBL] [Abstract][Full Text] [Related]
5. Human and rat glioma growth, invasion, and vascularization in a novel chick embryo brain tumor model. Cretu A; Fotos JS; Little BW; Galileo DS Clin Exp Metastasis; 2005; 22(3):225-36. PubMed ID: 16158250 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor. Bouchet A; Bidart M; Miladi I; Le Clec'h C; Serduc R; Coutton C; Regnard P; Khalil E; Dufort S; Lemasson B; Laissue J; Pelletier L; Le Duc G Tumour Biol; 2014 Jul; 35(7):6221-33. PubMed ID: 24633919 [TBL] [Abstract][Full Text] [Related]
7. Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model. Wang X; Duan X; Yang G; Zhang X; Deng L; Zheng H; Deng C; Wen J; Wang N; Peng C; Zhao X; Wei Y; Chen L PLoS One; 2011 Apr; 6(4):e18490. PubMed ID: 21559510 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of a transmembrane isoform of neural cell adhesion molecule alters the invasiveness of rat CNS-1 glioma. Owens GC; Orr EA; DeMasters BK; Muschel RJ; Berens ME; Kruse CA Cancer Res; 1998 May; 58(9):2020-8. PubMed ID: 9581848 [TBL] [Abstract][Full Text] [Related]
9. Characterization of gastrin-induced cytostatic effect on cell proliferation in experimental malignant gliomas. Lefranc F; Sadeghi N; Metens T; Brotchi J; Salmon I; Kiss R Neurosurgery; 2003 Apr; 52(4):881-90; discussion 890-1. PubMed ID: 12657185 [TBL] [Abstract][Full Text] [Related]
10. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo. Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140 [TBL] [Abstract][Full Text] [Related]
11. Glial cell line-derived neurotrophic factor (GDNF) and its receptor (GFR-alpha 1) are strongly expressed in human gliomas. Wiesenhofer B; Stockhammer G; Kostron H; Maier H; Hinterhuber H; Humpel C Acta Neuropathol; 2000 Feb; 99(2):131-7. PubMed ID: 10672319 [TBL] [Abstract][Full Text] [Related]
12. Establishment of a new cell line derived from a human gliosarcoma. Iwasaki K; Kikuchi H; Miyatake S; Kondo S; Oda Y Neurosurgery; 1992 Feb; 30(2):228-35. PubMed ID: 1545891 [TBL] [Abstract][Full Text] [Related]
14. Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. Barth RF; Kaur B J Neurooncol; 2009 Sep; 94(3):299-312. PubMed ID: 19381449 [TBL] [Abstract][Full Text] [Related]
15. 7-Hydroxystaurosporine-induced apoptosis in 9L glioma cells provides an effective antigen source for dendritic cells and yields a potent vaccine strategy in an intracranial glioma model. Witham TF; Erff ML; Okada H; Chambers WH; Pollack IF Neurosurgery; 2002 Jun; 50(6):1327-34; discussion 1334-5. PubMed ID: 12015852 [TBL] [Abstract][Full Text] [Related]
16. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity. Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123 [TBL] [Abstract][Full Text] [Related]
17. Expression of a soluble transforming growth factor-beta (TGFbeta) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcoma in vivo. Witham TF; Villa L; Yang T; Pollack IF; Okada H; Robbins PD; Chambers WH J Neurooncol; 2003; 64(1-2):63-9. PubMed ID: 12952287 [TBL] [Abstract][Full Text] [Related]
18. Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats. DiMeco F; Rhines LD; Hanes J; Tyler BM; Brat D; Torchiana E; Guarnieri M; Colombo MP; Pardoll DM; Finocchiaro G; Brem H; Olivi A J Neurosurg; 2000 Mar; 92(3):419-27. PubMed ID: 10701528 [TBL] [Abstract][Full Text] [Related]
19. Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat. Kooistra KL; Rodriguez M; Powis G; Yaksh TL; Harty GJ; Hilton JF; Laws ER Cancer Res; 1986 Jan; 46(1):317-23. PubMed ID: 3753551 [TBL] [Abstract][Full Text] [Related]
20. Intracranial inhibition of glioma cell growth by cyclooxygenase-2 inhibitor celecoxib. Nam DH; Park K; Park C; Im YH; Kim MH; Lee S; Hong SC; Shin HJ; Kim JH; Eoh W; McDonnell TJ Oncol Rep; 2004 Feb; 11(2):263-8. PubMed ID: 14719052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]